Royal Bank of Canada’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-500,223
| Closed | -$2.84M | – | 7573 |
|
|
2025
Q3 | $2.84M | Sell |
500,223
-3,484
| -0.7% | -$17.8K | ﹤0.01% | 3121 |
|
|
2025
Q2 | $1.92M | Buy |
503,707
+501,761
| +25,784% | +$1.56M | ﹤0.01% | 3339 |
|
|
2025
Q1 | $5K | Buy |
1,946
+1,138
| +141% | +$3.71K | ﹤0.01% | 6368 |
|
|
2024
Q4 | $3K | Sell |
808
-2,146
| -73% | -$8.22K | ﹤0.01% | 6665 |
|
|
2024
Q3 | $13K | Buy |
2,954
+276
| +10% | +$1.33K | ﹤0.01% | 6269 |
|
|
2024
Q2 | $12K | Buy |
2,678
+1,019
| +61% | +$4.48K | ﹤0.01% | 6278 |
|
|
2024
Q1 | $8K | Sell |
1,659
-8,018
| -83% | -$44.9K | ﹤0.01% | 6290 |
|
|
2023
Q4 | $61K | Buy |
9,677
+6,061
| +168% | +$34.7K | ﹤0.01% | 5901 |
|
|
2023
Q3 | $26K | Buy |
3,616
+1,724
| +91% | +$13.6K | ﹤0.01% | 6089 |
|
|
2023
Q2 | $19K | Buy |
+1,892
| New | +$19.7K | ﹤0.01% | 6244 |
|
|
2022
Q4 | – | Sell |
-12
| Closed | – | – | 7650 |
|
|
2022
Q3 | $0 | Sell |
12
-2,044
| -99% | -$10.9K | ﹤0.01% | 7798 |
|
|
2022
Q2 | $10K | Buy |
2,056
+2,000
| +3,571% | +$9.9K | ﹤0.01% | 6391 |
|
|
2022
Q1 | $0 | Sell |
56
-17
| -23% | -$83 | ﹤0.01% | 7979 |
|
|
2021
Q4 | $0 | Sell |
73
-6
| -8% | -$33 | ﹤0.01% | 7862 |
|
|
2021
Q3 | $1K | Sell |
79
-795
| -91% | -$4.75K | ﹤0.01% | 7502 |
|
|
2021
Q2 | $5K | Buy |
874
+33
| +4% | +$199 | ﹤0.01% | 7077 |
|
|
2021
Q1 | $6K | Buy |
841
+375
| +80% | +$2.57K | ﹤0.01% | 7001 |
|
|
2020
Q4 | $2K | Buy |
+466
| New | +$3.65K | ﹤0.01% | 6869 |
|
|
2020
Q2 | – | Sell |
-117
| Closed | -$1K | – | 6876 |
|
|
2020
Q1 | $1K | Buy |
+117
| New | +$848 | ﹤0.01% | 6484 |
|
|
2018
Q4 | – | Sell |
-10,227
| Closed | -$60K | – | 7066 |
|
|
2018
Q3 | $60K | Sell |
10,227
-9,843
| -49% | -$50.1K | ﹤0.01% | 5147 |
|
|
2018
Q2 | $113K | Buy |
+20,070
| New | +$206K | ﹤0.01% | 4748 |
|
Royal Bank of Canada's SCPH Position: Q4 2025 in Review
Royal Bank of Canada sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 500,223 shares — an estimated $2.84M sold.
Royal Bank of Canada first reported a position in SCPH in Q2 2018 and held it in 21 quarters. The position peaked at $2.84M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Royal Bank of Canada reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Royal Bank of Canada sold 500,223 scPharmaceuticals shares in Q4 2025, an estimated $2.84M.
- Royal Bank of Canada first reported a position in scPharmaceuticals in Q2 2018 and held it in 21 quarters.
- Royal Bank of Canada's scPharmaceuticals position peaked at $2.84M in Q3 2025.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.